Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis
ConclusionsEGFR exon 20 insertion mutations are rare in NSCLC. There is a high unmet need in patients with exon 20 insertions, including effective therapies. Prospective cohort studies are needed to better clinically characterise these patients.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Belgium Health | Cancer | Cancer & Oncology | Epidemiology | France Health | Germany Health | Italy Health | Lung Cancer | Netherlands Health | Non-Small Cell Lung Cancer | Politics | Spain Health | Study | Sweden Health | Switzerland Health | UK Health